These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9852304)

  • 21. [The role of telomerase activity in non-invasive diagnostics of bladder cancer].
    Glybochko PV; Alyaev JG; Potoldykova NV; Polyakovsky KA; Vinarov AZ; Glukhov AI; Gordeev SA
    Urologiia; 2016 Aug; (4):76-81. PubMed ID: 28247730
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Telomerase activity in 144 brain tumours.
    Sano T; Asai A; Mishima K; Fujimaki T; Kirino T
    Br J Cancer; 1998 May; 77(10):1633-7. PubMed ID: 9635839
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mad1 suppresses bladder cancer cell proliferation by inhibiting human telomerase reverse transcriptase transcription and telomerase activity.
    Zou L; Zhang P; Luo C; Tu Z
    Urology; 2006 Jun; 67(6):1335-40. PubMed ID: 16765199
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Telomerase activity as marker of superficial tumor of the bladder].
    Arias Fúnez F; Fernández Fernández E; Escudero Barrilero A; Moyano Jato A; Caso Peláez E
    Arch Esp Urol; 2000 Apr; 53(3):231-6. PubMed ID: 10851728
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Possible role of telomerase and sFas in pathogenesis of various bladder lesions associated with schistosomiasis.
    Shaker OG; Hammam O; Salehd A; el-Leithy T; Wishahi M
    Clin Biochem; 2009 Jun; 42(9):864-72. PubMed ID: 19272297
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical utility of telomerase for the diagnosis of malignant well-differentiated endocrine tumours.
    Vezzosi D; Bouisson M; Escourrou G; Laurell H; Selves J; Seguin P; Pradayrol L; Caron P; Buscail L
    Clin Endocrinol (Oxf); 2006 Jan; 64(1):63-7. PubMed ID: 16402930
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Quantitative analysis of telomerase activity in exfoliated urothelial cells for the diagnosis of bladder carcinoma].
    Yokota K; Kanayama H; Kagawa S; Abe-Hashimoto J; Hirose M; Yoshimura T
    Nihon Rinsho; 1998 May; 56(5):1292-8. PubMed ID: 9613140
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Telomerase activity in pancreatic endocrine tumours: a potential marker for malignancy.
    Lam KY; Lo CY; Fan ST; Luk JM
    Mol Pathol; 2000 Jun; 53(3):133-6. PubMed ID: 10897332
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Telomerase activity and cytokeratin 20 as markers for the detection and followup of transitional cell carcinoma: an unfulfilled promise.
    Cassel A; Rahat MA; Lahat N; Lindenfeld N; Mecz Y; Stein A
    J Urol; 2001 Sep; 166(3):841-4. PubMed ID: 11490230
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Telomerase activity in gastrointestinal, bladder and breast carcinomas and their clinical applications].
    Yoshida K; Toge T
    Nihon Rinsho; 2004 Jul; 62(7):1368-76. PubMed ID: 15283158
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Telomerase activity in bladder cancer tissues].
    Tang ZY; Yi H; Chen BL
    Hunan Yi Ke Da Xue Xue Bao; 2001 Apr; 26(2):167-8. PubMed ID: 12536659
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A non-isotopic method for the detection of telomerase activity in tumour tissues: TRAP-silver staining assay.
    Wen JM; Sun LB; Zhang M; Zheng MH
    Mol Pathol; 1998 Apr; 51(2):110-2. PubMed ID: 9713596
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Telomerase in human bladder cancer.
    Liu BC; Loughlin KR
    Urol Clin North Am; 2000 Feb; 27(1):115-23, x. PubMed ID: 10696250
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential induction in telomerase activity among bladder cancer patients and controls on gamma-radiation.
    Xing J; Zhu Y; Zhao H; Yang H; Chen M; Spitz MR; Wu X
    Cancer Epidemiol Biomarkers Prev; 2007 Mar; 16(3):606-9. PubMed ID: 17372259
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical evaluation of human telomerase catalytic subunit in bladder washings from patients with bladder cancer.
    Fukui T; Nonomura N; Tokizane T; Sato E; Ono Y; Harada Y; Nishimura K; Takahara S; Okuyama A
    Mol Urol; 2001; 5(1):19-23. PubMed ID: 11689147
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Significance of a simple assay of urine telomerase activity for the detection of bladder cancer].
    Iwabuchi I; Mori K; Yamamoto H; Hatakeyama S; Yoneyama T; Hashimoto Y; Koie T; Kamimura N; Suzuki T; Ohyama C
    Hinyokika Kiyo; 2010 Oct; 56(10):551-7. PubMed ID: 21063158
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Non-radioactive measurement of telomerase activity in human bladder cancer, bladder washings, and in urine.
    Heine B; Hummel M; Müller M; Heicappell R; Miller K; Stein H
    J Pathol; 1998 Jan; 184(1):71-6. PubMed ID: 9582530
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improvement in detecting telomerase activity using silica-based resin treatment: An experience of urine in bladder carcinoma.
    Yahata N; Nagao K; Ohyashiki JH; Hisatomi H; Ohyashiki K
    Int J Oncol; 1999 Apr; 14(4):709-12. PubMed ID: 10087318
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Telomerase activity in malignant and benign renal tumors.
    Müller M; Heicappell R; Krause H; Sachsinger J; Porsche C; Miller K
    Eur Urol; 1999; 35(3):249-55. PubMed ID: 10072629
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Telomerase activity and its inhibition in benign and malignant breast lesions.
    Sugino T; Yoshida K; Bolodeoku J; Tarin D; Goodison S
    J Pathol; 1997 Sep; 183(1):57-61. PubMed ID: 9370948
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.